[ad_1] New Delhi, Glenmark Pharmaceuticals on Thursday said it will launch a generic medication this month in the US market for the treatment of anaemia and to prevent serious side effects caused by large doses of medications that can reduce the impact of folic acid in the body. Glenmark Pharmaceuticals Inc., USA, a unit of…
[ad_1] NPPA Notifies New MRP for Key Cardiac, Diabetes and Antibiotic Drugs, Details We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Drugmaker Glenmark Pharmaceuticals Ltd on Thursday said it has received establishment inspection report from the US health regulator for its formulations manufacturing facility at Monroe, North Carolina, classifying the facility as voluntary action indicated. The inspection was conducted at the company’s manufacturing facility from June 9 to June 17, 2025, Glenmark Pharmaceuticals Ltd said…
[ad_1] Glenmark Pharmaceuticals on Tuesday said it has launched the world’s first nebulised, fixed-dose triple therapy for the treatment of chronic obstructive pulmonary disease. Nebzmart GFB Smartules and Airz FB Smartules combine three proven medicines – Glycopyrronium, Formoterol, and Budesonide – to reduce airway obstruction, inflammation, and improve lung function and symptom control, the Mumbai-based…
[ad_1] Glenmark Pharmaceuticals on Tuesday said it will launch a generic medication, used to treat high acid levels in the body, in the US market. Glenmark Pharmaceuticals Inc., USA, is gearing up to launch 8.4 per cent Sodium Bicarbonate Injection in a single-dose vial, the Mumbai-based drug firm said in a regulatory filing. The company’s…
[ad_1] Glenmark Pharmaceuticals Ltd on Wednesday announced signing of an exclusive licence and collaboration pact with Hengrui Pharma for development and commercialisation of Trastuzumab Rezetecan that is aimed at treating different types of cancer. The company’s arm Glenmark Specialty SA has entered into an exclusive licence and collaboration agreement with Hengrui Pharma for Trastuzumab Rezetecan…
[ad_1] Leadership Shift at Cipla: Umang Vohra to Exit, Achin Gupta Likely to Take Over as Global CEO We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Glenmark Pharmaceuticals on Friday said it has initiated a multi-country Phase 3 clinical trial for Envafolimab, a novel drug for third-stage non-small cell lung cancer. The company said it has received approval from the Drugs Controller General of India to begin patient enrolment and dosing in the country. In parallel, the drug firm has…
[ad_1] Glenmark Pharmaceuticals on Tuesday said it has launched a cancer treatment generic medication in the US market. Glenmark Pharmaceuticals Inc., USA, a subsidiary of the Mumbai-based drug firm, will launch Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials, it said in a statement. Glenmark’s product is therapeutically equivalent to the reference listed…